|
High $0.32 |
Low $0.30 |
Trades 243 |
Turnover $627,825 |
Volume 2,012,212 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $36,843,036 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (9-Nov) 20,215,263 (1.37%) (219th) |
|
52w High $0.470 |
52w Low $0.020 |
P/E 7.20 |
EPS -0.05 |
Immutep Investor Update
IMM released this announcement to the ASX on 18 February 2022, 8:11. The announcement is not marked as price sensitive, and is 13 page(s) in length and 1.22MB in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 1.198% short sold according to ASIC data. It was ranked the 164th most shorted stock on the ASX. It remains ranked 219th as of the latest reported data (09 November 2026).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Immutep Investor Update | 18 February 2022, 8:11 |
| Australian Patent Granted for Efti with PD-1 Inhibitors | 11 February 2022, 11:58 |
| Change in substantial holding | 2 February 2022, 8:25 |
| Death of Director Grant Chamberlain | 2 February 2022, 8:18 |
If you were already registered, log in here.